APOL1-mediated kidney disease

Clinical trials for APOL1-mediated kidney disease explained in plain language.

Never miss a new study

Get alerted when new APOL1-mediated kidney disease trials appear

Sign up with your email to follow new studies for APOL1-mediated kidney disease, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Completed 1

New drug targets genetic kidney disease in small trial

Disease control Completed

This study tests a drug called inaxaplin in 42 people with a genetic form of kidney disease linked to the APOL1 gene. The goal is to see if the drug can reduce protein in the urine, a sign of kidney damage, and to check for side effects. Participants take the drug as tablets, and…

Matched conditions: APOL1-MEDIATED KIDNEY DISEASE

Phase 2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control

Last updated Aug 22, 2026 00:00 UTC

APOL1-mediated kidney disease

Get alerted when new APOL1-mediated kidney disease trials appear

New drug targets genetic kidney disease in small trial